Pharmacological treatment of kleptomania and bulimia nervosa.
We describe three patients with concurrent DSM-III-R kleptomania and bulimia nervosa who all demonstrated a partial or complete response of both bulimic and kleptomanic symptoms to fluoxetine, trazodone, or tranylcypromine. These observations raise the possibility that pharmacological treatment may benefit kleptomania, and call for further study of the relationship between kleptomania, bulimia nervosa, and major depression.
McElroy
S L
SL
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02178.
Keck
P E
PE
Pope
H G
HG
Hudson
J I
JI
D000328:Adult; D002032:Bulimia / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D014191:Tranylcypromine / Q000627:therapeutic use*; D014196:Trazodone / Q000627:therapeutic use*
D005473:Fluoxetine; D014191:Tranylcypromine; D014196:Trazodone